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Atherosclerotic renal artery disease is a common cause of hypertension and chronic kidney disease that may progress into end
stage renal failure if not diagnosed and treated early. Renal artery stenosis (RAS) has been shown to be an independent risk factor
for mortality in patients with coronary artery disease. We sought to determine whether race is an independent risk factor for
developing RAS. A retrospective study was conducted including 324 patients with resistant hypertension who underwent renal
angiography with or without coronary angiography. In univariate analysis, Caucasian race was associated with signiﬁcant risk of
RAS (OR = 2.3, P = .01). However, this association was no longer signiﬁcant after correcting for additional clinical variables in a
multivariate model (OR = 1.5, P = .07). There was a strong association between smoking and RAS (OR 2.0, P = .02). We conclude
that traditional risk factors, especially smoking, rather than race, are the most important predictors of RAS development.
Copyright © 2009 Ayad Jazrawi et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Background
Atherosclerotic renal artery disease is a common cause of
hypertension and chronic kidney disease. End-stage renal
disease may result from hemodynamically signiﬁcant renal
artery stenosis (RAS) unless recognized and treated early [1–
3]. RAS has been shown to be an independent risk factor
for mortality in patients with coronary artery disease (CAD).
Patients with atherosclerotic RAS and CAD have twice the
risk of mortality even when coronary revisualization is
performed [4]. In addition to age, history of atherosclerosis
elsewhere, and smoking, Caucasian race has been proposed
as a risk factor for development of RAS [5, 6]. We sought to
investigate whether race is indeed an independent risk factor
for RAS.
2. Methods
This was a retrospective analysis. The study group included
patients who were referred for nonemergent coronary or
peripheral angiography between June 2007 and May 2008,
who also had hypertension resistant to medical therapy.
Resistant hypertension was deﬁned as a systolic blood
pressuregreaterthan140mmHgwhileonatleasttwoantihy-
pertensive medications. Patients with ﬁbromuscular dyspla-
sia, glomerular ﬁltration rate (GFR) <30mL/min/1.73m2,
and iodine allergy were excluded from the study. Patients
with glomerular ﬁltration rate (GFR) <30mL/min/1.73m2
were excluded since the purpose of the screening studies
was to diagnose RAS prior to developing end stage renal
disease. Patients with iodine allergy were excluded since they
were pretreated with steroid therapy. De Matteo and May
have suggested that glucocorticoids can cause renal artery
vasodilatation and therefore may underestimate the degree
of stenosis [7].
Patients who met the inclusion criteria for RAS screening
per ACC/AHA guideline [8] underwent renal artery angiog-
raphy to rule out RAS.
RAS was deﬁned as >70% luminal stenosis of the main
renal artery of either or both the kidneys.
Continuous variables were compared using t-test. Chi-
square test was used for comparison of categorical variables.2 Cardiology Research and Practice
Table 1: Clinical characteristics in patients of Caucasian and non-Caucasian race.
Caucasian race (N = 193) Non-Caucasian race (N = 130) P-value
Age (years) 70 66 .02
Gender, female 27.86 (90) 24.77 (80) .07
Hypertension 100 (193) 100 (130) .97
Diabetes mellitus 25.39 (82) 20.42 (66) .20
Hyperlipidemia 54.18 (175) 33.13 (107) .7
Peripheral vascular disease 31.37 (101) 18.01 (58) .19
Congestive heart failure 9.38 (30) 6.88 (22) .71
Cerebrovascular accident 12.69 (41) 9.60 (31) .58
Smoking 21.36 (69) 10.22 (33) .05
Serum creatinine (mg/dl ± SD) 1.6 ±0.31 .7 ±0.2. 2 8














Figure 1: Results of multivariable analysis of the risk of renal artery
stenosis.
Association between race and RAS was explored with
both univariate analysis and multivariate logistic regression
analysis. Multiple clinical variables that included age, gender,
race, history of diabetes mellitus, smoking, dyslipidemia,
peripheral vascular disease (PVD), and CAD were evaluated
as independent predictors of RAS.
Approval for the study was obtained from the hospital’s
institutional review board (IRB).
3. Results
There were 5012 patients who underwent diagnostic coro-
nary or peripheral angiographic procedures during the
study period. Of these, 324 patients also underwent renal
angiography at the same time due to persistent hypertension
whileonatleasttwoantihypertensiveagents.Inoneinstance,
the RAS was determined to be due to FMD and this patient
was excluded from the analysis. Therefore, the study group
included 323 patients. The mean age was 65 ± 10 years, 153
(47%) patients were male, 193 (59%) were Caucasian, and
130 (41%) were non-Caucasian. Atherosclerotic RAS was
diagnosed in 64/323 (20%) patients. The baseline clinical
characteristics were comparable between the Caucasian and
non-Caucasian patients except for higher age of Caucasian
patients and higher prevalence of smoking in non-Caucasian
patients (Table 1).
Table 2: Univariate analysis of the risk of renal artery stenosis.
Parameter Odds ratio 95% conﬁdence interval P-value
Diabetes mellitus 0.8 0.5–1.4 .48
Age >65 years 2.2 1.1–4.3 .02
PVD 1.7 1.0–3.0 .05
Hyperlipidemia 1.9 0.7–5.1 .19
Caucasian Race 2.3 1.3–4.4 .01






Diabetes mellitus 0.8 0.5–1.5 .55
Age (>65 years versus
<65 years)
1.8 0.9–3.7 .10
PVD 1.4 0.8–2.6 .24
Hyperlipidemia 1.2 0.4–3.3 .77
Smoking 2.0 1.2–3.7 .02
Caucasian race 1.5 0.8–2.1 .07
In univariate analysis (Table 2), age >65 years, history
of PVD and Caucasian race was associated with higher
prevalence of RAS. To correct for possible confounding
caused by diﬀerences of baseline characteristics in the two
groups, we carried out a multivariate logistic regression
analysis. In the multivariate model, the association between
race and RAS was no longer signiﬁcant (OR 1.5, 95% CI;
0.8–2.1P =.07).Smokingremainedastheonlycharacteristic
independently associated with RAS (Table 3, Figure 1).
4. Discussion
Renovascular disease is the most common cause of poten-
tially reversible secondary hypertension [9]. In the U.S.
general population, the prevalence of RAS is estimated to
be 0.13% but this incidence is much higher in patients
with hypertension who also have other risk factors for
cardiovascular disease [10] .S e v e r a ls t u d i e sh a v er e p o r t e dCardiology Research and Practice 3
that RAS appears to be more prevalent in Caucasian than
in non-Caucasian patients [5, 9]. As a result, it has been
suggested that non-Caucasian hypertensive patients should
not undergo screening for RAS [11]. Other reports have
questioned the association between race and RAS [12]. The
limitation of many previous studies has been the use of
duplex sonography for RAS screening. Although it is one of
the noninvasive modalities that is primarily used to screen
for RAS, it is highly operator dependent and technically
demanding[13].Catheterangiographyhasahigheraccuracy
in determining the severity of RAS [14].
In our study we deﬁned RAS as >70% stenosis, since this
degree of obstruction is believed to be associated with higher
mortality [15].
We took advantage of our diverse patient population and
an established program of screening renal angiography in
patients perceived to have high probability of atherosclerotic
RAS, as recommended by ACC/AHA guidelines for the
Management of patients with peripheral arterial disease [8].
We show that, although in univariate analysis Caucasian race
appeared to be a risk factor for RAS development, this was
no longer true in our multivariable model that corrected for
diﬀerencesinbaselinecharacteristics.Inourmodel,smoking
remained the only statistically signiﬁcant predictor in RAS, a
ﬁnding consistent with other reports [3, 16].
The study limitations include its retrospective nature
and an assumption that there was not a selection bias in
performing screening renal angiograms in the study group.
The study sample size was relatively small.
5. Conclusion
Our study demonstrates that traditional risk factors, espe-
ciallysmoking,remaincloselyassociatedwithatherosclerotic
renal artery stenosis. The presence of RAS should be
considered in patients with resistant hypertension regardless
of race.
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